top of page
logo_hand.png
side_logos-14.jpg
The Mina and Everard Goodman Faculty of Life Sciences
Bar Ilan Universty Logo

Publications

Gene-corrected regulatory T cell therapy for IL2RA deficiency

Alvin S Ha, Nechama Kalter, Michael Rosenberg, Luis A Acevedo, Brianna Liang, Weihong Liu, Sreenivasan Paruthiyil, Meenal Sinha, Alexander Vu, Vinh Nguyen, Zhongxia Qi, Netravathi Krishnappa, Jinna Shu, Jingwei Yu, Jason Catanzaro, Jeffrey A Bluestone, Qizhi Tang, Fyodor D Urnov, Alexander Marson, Ayal Hendel, Kevan C Herold, Brian R Shy, Jonathan H Esensten

Molecular Therapy, 2025

Proceedings of the second annual meeting of GenE-HumDi (COST Action 21113)

María Ortiz-Bueno, Iris Ramos-Hernández, Luis Algeciras-Jiménez, Nechama Kalter, Juan Roberto Rodríguez-Madoz, Jose Bonafont, Rajeevkumar Raveendran Nair, Oliver Feeney, Laura Torella, Lluis Montoliu, Petros Patsali, Claudio Mussolino, Yonglun Luo, Merita Xhetani, Alessia Cavazza, Ayal Hendel, Karim Benabdellah, Carsten Werner Lederer, Francisco J Molina-Estévez

Frontiers in Genome Editing, 2025

Off-target effects in CRISPR-Cas genome editing for human therapeutics: Progress and challenges

Nechama Kalter, Carla Fuster-García, Alfredo Silva, Víctor Ronco-Díaz, Stefano Roncelli, Giandomenico Turchiano, Jan Gorodkin, Toni Cathomen, Karim Benabdellah, Ciaran Lee, Ayal Hendel

Molecular Therapy Nucleic Acids, 2025

Navigating disruption in the PID landscape: embracing opportunities and anticipating threats in the next ten years

Lúcia Mamede, Roser Cantenys Sabà, Samya Van Coillie, Johan Prévot, Silvia Sánchez-Ramón, Cecilia Poli, Anne Barasa, Björn W Schuller, Ayal Hendel, Nicolas Garcelon, Cornelis Boersma, Pamela Lee, Claire Booth, Luigi D Notarangelo, Jose Drabwell, Nicholas L Rider, Frank J T Staal, Martin Van Hagen, Martine Pergent, Jacques G Rivière, Nizar Mahlaoui

Frontiers in Immunology, 2025

Precise measurement of CRISPR genome editing outcomes through single-cell DNA sequencing

Nechama Kalter, Saurabh Gulati, Michael Rosenberg, Qawer Ayaz, Joanne Nguyen, Shu Wang, Benjamin Schroeder, Chieh-Yuan Li, Ayal Hendel

Molecular Therapy Methods & Clinical Development, 2025

Targeting Tumor-Associated Sialic Acids Using Chimeric Switch Receptors Based on Siglec-9 Enhances the Antitumor Efficacy of Engineered T Cells

Vasyl Eisenberg, Shiran Hoogi, Erel Katzman, Nimrod Ben Haim, Raphaelle Zur-Toledano, Maria Radman, Yishai Reboh, Oranit Zadok, Iris Kamer, Jair Bar, Irit Sagi, Ayal Hendel, Cyrille J Cohen

Cancer Immunology Research, 2024

Quantifying allele-specific CRISPR editing activity with CRISPECTOR2.0

Guy Assa, Nechama Kalter, Michael Rosenberg, Avigail Beck, Oshry Markovich, Tanya Gontmakher, Ayal Hendel, Zohar Yakhini

Nucleic Acids Research, 2024

Evolution of Gene Therapy for Inborn Errors of Immunity

Ido Somekh, Ayal Hendel, Raz Somech

JAMA Pediatrics, 2024

Nicotinamide-Expanded Allogeneic Natural Killer Cells with CD38 Deletion, Expressing an Enhanced CD38 Chimeric Antigen Receptor, Target Multiple Myeloma Cells

Avishay Edri, Nimrod Ben-Haim, Astar Hailu, Nurit Brycman, Orit Berhani-Zipori, Julia Rifman, Sherri Cohen, Dima Yackoubov, Michael Rosenberg, Ronit Simantov, Hideshima Teru, Keiji Kurata, Kenneth Carl Anderson, Ayal Hendel, Aviad Pato, Yona Geffen

International Journal of Molecular Sciences, 2023

CRISPR-Cas9 engineering of the RAG2 locus via complete coding sequence replacement for therapeutic applications

Daniel Allen, Orli Knop, Bryan Itkowitz, Nechama Kalter, Michael Rosenberg, Ortal Iancu, Katia Beider, Yu Nee Lee, Arnon Nagler, Raz Somech, Ayal Hendel

Nature Communications, 2023

Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi

Alessia Cavazza, Ayal Hendel, Rasmus O Bak, Paula Rio, Marc Güell, Duško Lainšček, Virginia Arechavala-Gomeza, Ling Peng, Fatma Zehra Hapil, Joshua Harvey, Francisco G Ortega, Coral Gonzalez-Martinez, Carsten W Lederer, Kasper Mikkelsen, Giedrius Gasiunas, Nechama Kalter, Manuel A F V Gonçalves, Julie Petersen, Alejandro Garanto, Lluis Montoliu, Marcello Maresca, Stefan E Seemann, Jan Gorodkin, Loubna Mazini, Rosario Sanchez, Juan R Rodriguez-Madoz, Noelia Maldonado-Pérez, Torella Laura, Michael Schmueck-Henneresse, Cristina Maccalli, Julian Grünewald, Gloria Carmona, Neli Kachamakova-Trojanowska, Annarita Miccio, Francisco Martin, Giandomenico Turchiano, Toni Cathomen, Yonglun Luo, Shengdar Q Tsai, Karim Benabdellah; COST Action CA21113

Molecular Therapy - Nucleic Acids, 2023

Homology-Directed-Repair-Based Genome Editing in HSPCs for the Treatment of Inborn Errors of Immunity and Blood Disorders

Daniel Allen, Nechama Kalter, Michael Rosenberg, Ayal Hendel

Pharmaceutics, 2023

Editorial: CRISPR and beyond: Cutting-edge technologies for gene correction in therapeutic applications

Ayal Hendel, Rasmus O Bak

Frontiers, 2023

Multiplex HDR for disease and correction modeling of SCID by CRISPR genome editing in human HSPCs

Ortal Iancu, Daniel Allen, Orli Knop, Yonathan Zehavi, Dor Breier, Adaya Arbiv, Atar Lev, Yu Nee Lee, Katia Beider, Arnon Nagler, Raz Somech, Ayal Hendel

Molecular Therapy Nucleic Acids, 2022

Lessons Learned From Five Years of Newborn Screening for Severe Combined Immunodeficiency in Israel

Atar Lev, Idan Sharir, Amos J Simon, Shiran Levy, Yu Nee Lee, Shirly Frizinsky, Suha Daas, Talia Saraf-Levy, Arnon Broides, Amit Nahum, Suhair Hanna, Polina Stepensky, Ori Toker, Ilan Dalal, Amos Etzioni, Jerry Stein, Etai Adam, Ayal Hendel, Nufar Marcus, Shlomo Almashanu, Raz Somech

Journal of Allergy and Clinical Immunology, 2022

Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients

Ori Hassin, Nishanth Belugali Nataraj, Michal Shreberk-Shaked, Yael Aylon, Rona Yaeger, Giulia Fontemaggi, Saptaparna Mukherjee, Martino Maddalena, Adi Avioz, Ortal Iancu, Giuseppe Mallel, Anat Gershoni, Inna Grosheva, Ester Feldmesser, Shifra Ben-Dor, Ofra Golani, Ayal Hendel, Giovanni Blandino, David Kelsen, Yosef Yarden, Moshe Oren

Nature Communications, 2022

Microfluidic tool for rapid functional characterization of CRISPR complexes

Dana Peleg-Chen, Guy Shuvali, Lev Brio, Amit Ifrach, Ortal Iancu, Efrat Barbiro-Michaely, Ayal Hendel, Doron Gerber

New Biotechnology, 2022

Stepwise-edited, human melanoma models reveal mutations' effect on tumor and microenvironment

Eran Hodis, Elena Torlai Triglia, John Y H Kwon, Tommaso Biancalani, Labib R Zakka, Saurabh Parkar, Jan-Christian Hütter, Lorenzo Buffoni, Toni M Delorey, Devan Phillips, Danielle Dionne, Lan T Nguyen, Denis Schapiro, Zoltan Maliga, Connor A Jacobson, Ayal Hendel, Orit Rozenblatt-Rosen, Martin C Mihm Jr, Levi A Garraway, Aviv Regev

Science, 2022

High-Throughput Imaging of CRISPR- and Recombinant Adeno-Associated Virus-Induced DNA Damage Response in Human Hematopoietic Stem and Progenitor Cells

Daniel Allen, Lucien E Weiss, Alon Saguy, Michael Rosenberg, Ortal Iancu, Omri Matalon, Ciaran Lee, Katia Beider, Arnon Nagler, Yoav Shechtman, Ayal Hendel

CRISPR Journal, 2022

CRISPECTOR provides accurate estimation of genome editing translocation and off-target activity from comparative NGS data

Ido Amit, Ortal Iancu, Alona Levy-Jurgenson, Gavin Kurgan, Matthew S McNeill, Garrett R Rettig, Daniel Allen, Dor Breier, Nimrod Ben Haim, Yu Wang, Leon Anavy, Ayal Hendel, Zohar Yakhini

Nature Communications, 2021

Exploring genetic defects in adults who were clinically diagnosed as severe combined immune deficiency during infancy

Ido Somekh, Atar Lev, Ortal Barel, Yu Nee Lee, Ayal Hendel, Amos J Simon, Raz Somech

Immunologic Research , 2021

Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects

Atar Lev, Yu Nee Lee, Guangping Sun, Enas Hallumi, Amos J Simon, Keren S Zrihen, Shiran Levy, Tal Beit Halevi, Maria Papazian, Neta Shwartz, Ido Somekh, Sarina Levy-Mendelovich, Baruch Wolach, Ronit Gavrieli, Helly Vernitsky, Ortal Barel, Elisheva Javasky, Tali Stauber, Chi A Ma, Yuan Zhang, Ninette Amariglio, Gideon Rechavi, Ayal Hendel, Deborah Yablonski, Joshua D Milner, Raz Somech

Journal of Experimental Medicine, 2021

Using Synthetically Engineered Guide RNAs to Enhance CRISPR Genome Editing Systems in Mammalian Cells

Daniel Allen, Michael Rosenberg, Ayal Hendel

Frontiers, 2021

Chemical Modification of Guide RNAs for Improved CRISPR Activity in CD34+ Human Hematopoietic Stem and Progenitor Cells

Jenny Shapiro, Adi Tovin, Ortal Iancu, Daniel Allen, Ayal Hendel

Methods in Molecular Biology, 2021

The Cell Line A-to-I RNA Editing Catalogue

Amos A Schaffer, Eli Kopel, Ayal Hendel, Ernesto Picardi, Erez Y Levanon, Eli Eisenberg

Nucleic Acids Research, 2020

Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant System

Jenny Shapiro, Ortal Iancu, Ashley M Jacobi, Matthew S McNeill, Rolf Turk, Garrett R Rettig, Ido Amit, Adi Tovin-Recht, Zohar Yakhini, Mark A Behlke, Ayal Hendel

Molecular Therapy - Methods & Clinical Development, 2020

CRISPR-based Gene Editing Enables FOXP3 Gene Repair in IPEX Patient Cells

M Goodwin, E Lee, U Lakshmanan, S Shipp, L Froessl, F Barzaghi, L Passerini, M Narula, A Sheikali, C M Lee, G Bao, C S Bauer, H K Miller, M Garcia-Lloret, M J Butte, A Bertaina, A Shah, M Pavel-Dinu, A Hendel, M Porteus, M G Roncarolo, R Bacchetta

Science Advances, 2020

Reduced function and diversity of T cell repertoire and distinct clinical course in patients with IL7RA mutation

Atar Lev, Amos J Simon, Ortal Barel, Eran Eyal, Efrat Glick-Saar, Omri Nayshool, Ohad Birk, Tali Stauber, Amit Hochberg, Arnon Broides, Shlomo Almashanu, Ayal Hendel, Yu Nee Lee, Raz Somech

Frontiers in Immunology, 2019

Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34+ Hematopoietic Stem and Progenitor Cells

M Kyle Cromer, Sriram Vaidyanathan, Daniel E Ryan, Bo Curry, Anne Bergstrom Lucas, Joab Camarena, Milan Kaushik, Sarah R Hay, Renata M Martin, Israel Steinfeld, Rasmus O Bak, Daniel P Dever, Ayal Hendel, Laurakay Bruhn, Matthew H Porteus

Molecular Therapy, 2018

Uridine Depletion and Chemical Modification Increase Cas9 mRNA Activity and Reduce Immunogenicity without HPLC Purification

Sriram Vaidyanathan, Krist T Azizian, A K M Ashiqul Haque, Jordana M Henderson, Ayal Hendel, Sabrina Shore, Justin S Antony, Richard I Hogrefe, Michael S D Kormann, Matthew H Porteus, Anton P McCaffrey

Molecular Therapy Nucleic Acids, 2018

Therapeutic Genome Editing and its Potential Enhancement through CRISPR Guide RNA and Cas9 Modifications

Nurit Assia Batzir, Adi Tovin, Ayal Hendel

Pediatr Endocrinol Rev, 2017

A Comprehensive TALEN-Based Knockout Library for Generating Human-Induced Pluripotent Stem Cell-Based Models for Cardiovascular Diseases

Ioannis Karakikes, Vittavat Termglinchan, Diana A Cepeda, Jaecheol Lee, Sebastian Diecke, Ayal Hendel, Ilanit Itzhaki, Mohamed Ameen, Rajani Shrestha, Haodi Wu, Ning Ma, Ning-Yi Shao, Timon Seeger, Nicole Woo, Kitchener D Wilson, Elena Matsa, Matthew H Porteus, Vittorio Sebastiano, Joseph C Wu

Circulation research, 2017

CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells

Daniel P Dever, Rasmus O Bak, Andreas Reinisch, Joab Camarena, Gabriel Washington, Carmencita E Nicolas, Mara Pavel-Dinu, Nivi Saxena, Alec B Wilkens, Sruthi Mantri, Nobuko Uchida, Ayal Hendel, Anupama Narla, Ravindra Majeti, Kenneth I Weinberg, Matthew H Porteus

Nature, 2016

Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells

Ayal Hendel, Rasmus O Bak, Joseph T Clark, Andrew B Kennedy, Daniel E Ryan, Subhadeep Roy, Israel Steinfeld, Benjamin D Lunstad, Robert J Kaiser, Alec B Wilkens, Rosa Bacchetta, Anya Tsalenko, Douglas Dellinger, Laurakay Bruhn, Matthew H Porteus

Nature Biotechnology, 2015

Quantifying on- and off-target genome editing

Ayal Hendel, Eli J Fine, Gang Bao, Matthew H Porteus

Trends in Biotechnology, 2015

Quantifying Genome Editing Outcomes at Endogenous Loci using SMRT Sequencing

Ayal Hendel, Eric J Kildebeck, Eli J Fine, Niraj Punjya, Vittorio Sebastiano, Gang Bao, Matthew H Porteus

Cell Reports, 2014

Nuclease-mediated gene editing by homologous recombination of the human globin locus

Richard A Voit, Ayal Hendel, Shondra M Pruett-Miller, Matthew H Porteus

Nucleic Acids Research, 2014

DNA damage bypass operates in the S and G2 phases of the cell cycle and exhibits differential mutagenicity

Noam Diamant, Ayal Hendel, Ilan Vered, Thomas Carell, Thomas Reissner, Niels de Wind, Nicholas Geacinov, Zvi Livneh

Nucleic Acids Research, 2012

Quantitative measurement of translesion DNA synthesis in mammalian cells

Omer Ziv, Noam Diamant, Sigal Shachar, Ayal Hendel, Zvi Livneh

Methods in Molecular Biology, 2012

PCNA Ubiquitination Is Important, But Not Essential for Translesion DNA Synthesis in Mammalian Cells

Ayal Hendel, Peter H L Krijger, Noam Diamant, Zohar Goren, Petra Langerak, Jungmin Kim, Thomas Reissner, Kyoo-young Lee, Nicholas E Geacintov, Thomas Carell, Kyungjae Myung, Satoshi Tateishi, Alan D'Andrea, Heinz Jacobs, Zvi Livneh

PLoS Genetics, 2011

Repair of gaps opposite lesions by homologous recombination in mammalian cells

Sheera Adar, Lior Izhar, Ayal Hendel, Nicholas Geacintov, Zvi Livneh

Nucleic Acids Research, 2009

Repair of gaps opposite lesions by homologous recombination in mammalian cells

Sheera Adar, Lior Izhar, Ayal Hendel, Nicholas Geacintov, Zvi Livneh

Nucleic Acids Research, 2009

Separate domains of Rev1 mediate two modes of DNA damage bypass in mammalian cells

Jacob G Jansen, Anastasia Tsaalbi-Shtylik, Giel Hendriks, Himabindu Gali, Ayal Hendel, Fredrik Johansson, Klaus Erixon, Zvi Livneh, Leon H F Mullenders, Lajos Haracska, Niels de Wind

Molecular and Cellular Biology, 2009

Reduced efficiency and increased mutagenicity of translesion DNA synthesis across a TT cyclobutane pyrimidine dimer, but not a TT 6-4 photoproduct, in human cells lacking DNA polymerase eta

Ayal Hendel, Omer Ziv, Quentin Gueranger, Nicholas Geacintov, Zvi Livneh

DNA Repair, 2008

Single-stranded DNA-binding protein recruits DNA polymerase V to primer termini on RecA-coated DNA

Gali Arad, Ayal Hendel, Claus Urbanke, Ute Curth, Zvi Livneh

Journal of Biological Chemistry, 2008

Mechanism of Translesion DNA Synthesis in Escherichia coli. DNA Damage Recognition

Zvi Livneh, Ayelet Maor-Shoshani, Moshe Goldsmith, Gali Arad, Ayal Hendel, Lior Izhar

DNA Damage Recognition, 2005
bottom of page